Impact of Educational Intervention on Pharmacists’ Knowledge of Therapy of Chronic Kidney Disease
DOI:
https://doi.org/10.4314/ajbr.v27i1.9الكلمات المفتاحية:
pharmacists knowledge، renal insufficiency، chronic، humansالملخص
The objectives of this study were to determine the knowledge of pharmacists regarding chronic kidney disease and to determine the impact of socio-demographic characteristics on pharmacists’ knowledge as well as to determine the impact of educational intervention on pharmacists’ knowledge of chronic kidney disease. The study was a prospective, cross-sectional interventional study undertaken in the Department of Pharmacy, Federal Medical Centre Asaba and the Department of Pharmacy Delta State University Teaching Hospital Oghara, as well as in all the Central hospitals in the State for over a period of one year. Data collection was done using the kidney knowledge survey (KIKS) 28-items questionnaire. The data on the retrieved copies of the questionnaire were analyzed with Statistical Package for Social Sciences version 20. The average knowledge of the respondents in the various centers surveyed was good. There was no statistically significant difference in the overall mean knowledge score between the centers p>0.05. However, DELSUTH Oghara had a higher overall mean score of 21.89±3.01 (78.2%), followed by Federal Medical Center Asaba 20.41±2.61 (72.9%) and Central hospitals 19.40±3.72 (69.3%). Socio demographics had no impact on the average knowledge of the pharmacists. The intervention programme impacted positively on pharmacists’ knowledge of chronic kidney disease.
المراجع
Agaba EI, Agaba PA, Dankyau M, Akanbi MO, Daniyam CA, Okeke EN (2012). Specialist Physician Knowledge of Chronic Kidney Disease. A Comparison of Internees and Family Physicians in West Africa. African Journal of Primary Health Care and Family Medicine; 4:319.
Agaba EI, Akinbuwa BA, Agaba PA, Daniyam CA, Okeke EN, Tzamaloukas AH (2011). A Cross Sectional Study of the Knowledge and Practice Patterns of Family Medicine Residents Regarding Chronic Kidney Disease Screening. Niger Med J; 52: 74-78
Agrawal V, Ghosh AK, Barnes MA, McCullough PA (2009). Perception of Indications for Nephrology Referral among Internal Medicine Residents: A National Online Survey. Clinical Journal of the American Society of Nephrology; 4: 323-8.
Bisheya AF, El-Mijbri SAB, Beshyah SA, Sherif I (2011). Community Pharmacists’ Knowledge, Attitude and Practice towards Diabetes Care in Tripoli, Libya. Ibnosina Journal of Medicine and Biomedical Sciences; 3: 89-95.
Burton C, Harris KP (1996). The Role of Proteinuria in the Progression of Chronic Renal Failure. Am J Kidney Dis; 27: 765-75
Chen HY, Lee TY, Huang WT, Chang CJ, Chen CM (2004). The short term impact of a continuing education program on Pharmacists’ Knowledge and Attitude towards Diabetes. American Journal of Pharmaceutical Education; 68 (5) article 121
Chuokem S, Nchifor PK, Halle M (2016). Knowledge of Physicians on Chronic Kidney Disease and their Attitudes towards Referral in Two Cities in Cameroon: a Cross-Sectional Study. BMC notes; 9: 29 doi: 10. 1186/s13104-016-1845-6
Curtin RB, Sitter DC, Schatell D, Chewning BA (2004). Self-Management, Knowledge, and Functioning and Well-Being of Patients on Hemodialysis. Nephrology Nursing Journal; 31(4): 378-386.
Fitzgerald JT, Funnell MM, Hess GE, Patricia A, Anderson RM, Hiss RG, Davis WK (1998). The Reliability and Validity of a Brief Diabetes Knowledge Test. Diabetes Care; 21:706-10.
Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, E linder C, Blot WJ, McLaughlin JK, et. al.,( 2001). Acetaminophen, Aspirin and Chronic Renal Failure. New England Journal of Medicine; 345: 1801-8.
Godswill OC, Ogbonna U, Justina CO, Ezeani IU (2016). Identification and Prereferral Care for Patients with Chronic Kidney Disease by Nigerian Family Medicine Trainee. Afr J Med Health Sci; 15:41-5
Gooch K, Culleton BF, Manns BJ, Zhong J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgam BR (2007). NSAID Use and Progression of Chronic Kidney Disease. American Journal of Medicine; 120: e1-7.
Haines A and Donald A (1998). Getting research funding, into practice, making better use of research results. British Med J.; 317:72-5
Harkonen S, Kjellstrand C. Contrast nephropathy. Am J Nephrol 1981; 1: 69-77
Huizinga MM, Elasy TA, Wallson KA, Cavanaugh K, Davis D, Gregory RP, Fuchs LS, Malone R, Cherrington A, DeWalt DA, Buse J, Pignone M, Rothman RL (2008). Development and Validation of the Diabetes Numeracy Test (DNT). BioMed Central Health Service Research; 8:96.
Ijoma CK, Ulasi II, Kalu AO (1998). “Cost Implications of Treatment of End-Stage Renal Disease in Nigeria,” Journal of College of Medicine; 3: 95–96.
Kadiri S, Walker O, Salako BL, Akinkugbe O (1999). Blood Pressure, Hypertension and Correlates in Urbanized Workers in Ibadan, Nigeria: a revisit. Journal of Human Hypertension; 13:23–7.
Lenz O, Fomoni A (2006). Chronic Kidney Disease Care Delivered by US Family Medicine and Internal Medicine Trainees. Results from an Online Survey. BMC Med; 4:30
Levey AS, Atkins R, Coresh J, Collin AJ, Eckardt KU, Nahas ME, Jaber BL, Jaduol M, Levin A, Powe NR, Rosert J, Wheeler DC, Lameire N, Eknoyam G (2007). Chronic Kidney Disease as a Global Public Health Problem: Approaches and Initiatives- A Position Statement from Kidney Disease Improving Global Outcomes. Kidney International; 72: 247-259.
Longo, D, Fauci A, Kasper D, Hauser SJ, Loscalzo JJ.. Harrison's Principles of Internal Medicine, 18 edition. 2011; McGraw-Hill Professional.
Mahmud M, Hussain N, Kamal A, Samon Z, Khan W (2016). Doctors’ Knowledge and Practices Regarding Chronic Kidney Disease at Tertiary Care Hospital. Int Arch Med; 9
Nanra RS, Stuart-Taylor J, de Leon AH, White KH. (1978). Analgesic Nephropathy: Etiology, Clinical Syndrome, and Clinicopathologic Correlations in Australia. Kidney International; 13: 79-92.
National Kidney Foundation (2003). K/DOQI Clinical Practice Guidelines for the Management of Dyslipidemias in Patients with Kidney Disease. Am J Kidney Dis; 41 (4 suppl 3): I-IV. S1-91.
National Kidney Foundation (2004). K/DOQI Clinical Practice Guideline on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis; 43 (5 Suppl 1): S1-290.
National Kidney Foundation (2005). K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis; 45 (4 Suppl 3): S1-153.
National Kidney Foundation (2000). K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis; 35 (6 Suppl 2): S1-140
Osborn CY, Davis TC, Bailey SC, Wolf MS (2010). Health Literacy in the Context of HIV Treatment: Introducing the Brief Estimate of Health Knowledge and Action (BEHKA)-HIV version. AIDS Behavior; 14: 181-188.
Schena FP (2000). Epidemiology of End-Stage Renal Disease: International Comparisons of Renal Replacement Therapy. Kidney International; 57:39–45.
Spreight J, Bradley C (2001). The ADKnowl: Identifying knowledge Deficits in Diabetes Care. Diabetes Med; 18: 626-33
Wright JA, Wallston KA, Elasy TA, Ikizler TA, Cavanaugh KL (2011). Development and Results of a Kidney Disease Knowledge Survey Given to Patients with CKD. American Journal of kidney Disease; 57: 387-395.
Yaqub S, Kashif W, Raza MO, Aagil H, Shahab A, Chaudhary MA, Hussain SA (2013). General Practitioners’ Knowledge and Approach to Chronic Kidney Disease in Karachi, Pakistan. Indian Journal of Nephrology; 23: 184-190.
التنزيلات
منشور
إصدار
القسم
الرخصة
الحقوق الفكرية (c) 2024 African Journal of Biomedical Research
هذا العمل مرخص بموجب Creative Commons Attribution 4.0 International License.
